| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 271.49 Billion | USD 621.80 Billion | 8.64% | 2024 |
FrequentlyAsked Questions
The global healthcare contract development and manufacturing organization market is expected to grow due to pharmaceutical outsourcing trends, rising biologics demand, and the need for cost-effective drug development.
According to a study, the global healthcare contract development and manufacturing organization market size was worth around USD 271.49 Billion in 2024 and is expected to reach USD 621.80 Billion by 2034.
The global healthcare contract development and manufacturing organization market is expected to grow at a CAGR of 8.64% during the forecast period.
North America is expected to dominate the healthcare contract development and manufacturing organization market over the forecast period.
Leading players in the global healthcare contract development and manufacturing organization market include Lonza Group, Thermo Fisher Scientific, Catalent, IQVIA, Recipharm, Siegfried Holding, Jabil, Sanmina Corporation, Flex, Covance (Labcorp), Samsung Biologics, WuXi AppTec, Boehringer Ingelheim BioXcellence, Fujifilm Diosynth Biotechnologies, Patheon, among others.
The report explores crucial aspects of the healthcare contract development and manufacturing organization market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients